Shopping Cart
- Remove All
Your shopping cart is currently empty
N-Caffeoyltryptophan (trans-Caffeoyl-L-tryptophan), a potential Sirt inhibitor, is screened using coffee extract. N-Caffeoyltryptophan inhibited Sirt2 (IC50; 8.7 μM) better than Sirt1(IC50; 34μM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $106 | In Stock | |
| 2 mg | $148 | In Stock | |
| 5 mg | $239 | In Stock | |
| 10 mg | $355 | In Stock | |
| 25 mg | $588 | In Stock | |
| 50 mg | $838 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $259 | In Stock |
| Description | N-Caffeoyltryptophan (trans-Caffeoyl-L-tryptophan), a potential Sirt inhibitor, is screened using coffee extract. N-Caffeoyltryptophan inhibited Sirt2 (IC50; 8.7 μM) better than Sirt1(IC50; 34μM). |
| Targets&IC50 | SIRT2:8.7 μM, SIRT1:34μM |
| In vitro | In cellular levels,N-Caffeoyltryptophan was able to increase the acetylation of total lysine, cortactin and histone H3 in neuronal NG108-15 cells. In the same cells, the amide also increased the acetylation of lysine (K382) in p53, but not (K305)[1]. |
| Synonyms | trans-Caffeoyl-L-tryptophan |
| Molecular Weight | 366.37 |
| Formula | C20H18N2O5 |
| Cas No. | 109163-69-1 |
| Smiles | C([C@H](NC(/C=C/C1=CC(O)=C(O)C=C1)=O)C(O)=O)C=2C=3C(NC2)=CC=CC3 |
| Relative Density. | 1.460 g/cm3 (Predicted) |
| Sequence | coumaroyl(3-OH)-Trp |
| Sequence Short | W |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (122.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.